KALA BIO KALA 深 沪
等待开盘 08-25 09:30:00 美东时间
0.7954
-0.025
-3.01%
华盛通- 最 高0.84
- 今 开0.82
- 成交量 5.47万股
- 最 低 0.7817
- 昨 收 0.8201
- 总市值 1538.29万
- 52周最高 1030.00
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 0.59
- 委 比 96.37%
- 总股本 1933.98万
- 历史最高 66875.00
- 量 比 0.77
- 振 幅 7.11%
- 历史最低 0.7817
- 每 手 1
- 风险率 229.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent increase over losses of $(85.64) per share from the same period last year. The company reported $0.00 in sales this quarter. This is the same as the same period last year.
08-20 05:07
KALA BIO Announces Brief Delay in Quarterly Filing
KALA BIO ( ($KALA) ) has released a notification of late filing. KALA BIO, Inc....
08-15 00:35
Kala Bio Files Prospectus Supplement for New Securities Offering
An update from KALA BIO ( ($KALA) ) is now available. On July 22, 2026, Kala Bi...
07-23 18:35
Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same
05-16 07:12
KALA BIO shares are trading lower after the company announced a 1-for-50 reverse stock split.
KALA BIO shares are trading lower after the company announced a 1-for-50 revers...
05-07 21:24
Kala Bio Announces 1-For-50 Reverse Stock Split, Effective May 11
KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock") at a ratio of 1 post-split
05-07 21:03
Kala Bio Q4 EPS $0.86 Beats $(1.44) Estimate, Sales $0.00
Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $(1.44) by 159.72 percent. This is a 149.43 percent increase over losses of $(1.74) per share from the
04-16 05:26
Top 3 Health Care Stocks Which Could Blast Off This Quarter
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)
04-08 18:40
Kala Bio Highlights Launch Of Agentic AI Platform
The Bionic Intelligence Research Agent is a fully autonomous AI research specialist built for the biotechnology and pharmaceutical sectors
03-30 20:32
EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch
Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.
03-30 20:31
